跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RESPIGAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RESPIGAM
Authorized
STANDARD
RESPIGAM
MedImmune LLC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
865442505620f400
Company
MedImmune LLC
Type
Standard
Approval Details
Approval Id
865442505620f400
Drug Approval Canada Name
RESPIGAM
Product Name
RESPIGAM
Status
Cancelled Pre Market
Status Date
2017-08-28
Din
02232480
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
80:04.00
Atc Original
J06BA02 IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASC. ADM.
Atc Name
j 06 ba 02
Aig Number
0132654003
Company Name
MedImmune LLC
Company Address
ACCOUNTS PAYABLE, One Medimmune Way, Gaithersburg, Maryland, United States, 20878
Company Detail Path
/organization/medimmune-llc
Company Information
Pharmaceutical Company Name
MedImmune LLC
Country Name
United States
Website
http://medimmune.com
Active Ingredients
RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
50 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
865442505620f400
Type
Standard
Back to Health Canada Approvals